Literature DB >> 20001914

The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.

Jeffrey Copps1, Richard F Murphy, Sándor Lovas.   

Abstract

The gastrointestinal peptide hormone gastrin is responsible for initiating the release of gastric acid in the stomach in response to the presence of food and/or humoral factors such as gastrin releasing peptide. However, it has a role in the growth and maintenance of the gastric epithelium, and has been implicated in the formation and growth of gastric cancers. Hypergastrinemia resulting from atrophic gastritis and pernicious anemia leads to hyperplasia and carcinoid formation in rats, and contributes to tumor formation in humans. Additionally, gastrin has been suspected to play a role in the formation and growth of cancers of the colon, but recent studies have instead implicated gastrin processing intermediates, such as gastrin-17-Gly, acting upon a putative, non-cholecystokinin receptor. This review summarizes the production and chemical structures of gastrin and of the processing intermediate gastrin-17-Gly, as well as their activities in the gastrointestinal tract, particularly the promotion of colon cancers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20001914      PMCID: PMC2872940          DOI: 10.2174/092986609789839269

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  284 in total

Review 1.  Transgenic mice expressing cholecystokinin 2 receptors in the pancreas.

Authors:  Pascal Clerc; Corinne Saillan-Barreau; Christine Desbois; Lucien Pradayrol; Daniel Fourmy; Marlène Dufresne
Journal:  Pharmacol Toxicol       Date:  2002-12

2.  Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice.

Authors:  M D Barrachina; V Martínez; L Wang; J Y Wei; Y Taché
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

3.  N alpha-Glycosylgastrin-related peptides. Synthesis, characterization and biological activity.

Authors:  A Previero; G Mourier; J P Bali; M F Lignon; L Moroder
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1982-08

4.  Involvement of a pertussis toxin-sensitive G protein in the action of gastrin on gastric parietal cells.

Authors:  S Roche; J P Bali; R Magous
Journal:  Biochim Biophys Acta       Date:  1990-12-10

5.  Effects of partial resection of acid-secreting mucosa on plasma gastrin and enterochromaffin-like cells in the rat stomach.

Authors:  B Ryberg; E Carlsson; R Håkanson; L Lundell; H Mattsson; F Sundler
Journal:  Digestion       Date:  1990       Impact factor: 3.216

6.  Expression, processing, and secretion of gastrin in patients with colorectal carcinoma.

Authors:  G D Ciccotosto; A McLeish; K J Hardy; A Shulkes
Journal:  Gastroenterology       Date:  1995-10       Impact factor: 22.682

7.  Molecular and pharmacological characterization of the human CCKB receptor.

Authors:  J Denyer; J Gray; M Wong; M Stolz; S Tate
Journal:  Eur J Pharmacol       Date:  1994-06-15       Impact factor: 4.432

8.  Lipid-induced ordered conformation of some peptide hormones and bioactive oligopeptides: predominance of helix over beta form.

Authors:  C S Wu; A Hachimori; J T Yang
Journal:  Biochemistry       Date:  1982-09-14       Impact factor: 3.162

9.  Growth of colorectal carcinoma cells: regulation in vitro by gastrin, pentagastrin and the gastrin-receptor antagonist proglumide.

Authors:  A Imdahl; S Eggstein; C Crone; E H Farthmann
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

10.  Gastrin and colorectal cancer: a prospective study.

Authors:  C M Thorburn; G D Friedman; C J Dickinson; J H Vogelman; N Orentreich; J Parsonnet
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

View more
  1 in total

1.  Diagnostic performances of pepsinogens and gastrin-17 for atrophic gastritis and gastric cancer in Mongolian subjects.

Authors:  Ganchimeg Dondov; Dashmaa Amarbayasgalan; Batbold Batsaikhan; Tegshjargal Badamjav; Batchimeg Batbaatar; Baljinnyam Tuvdenjamts; Nasanjargal Tumurbat; Bayar Davaa; Erkhembulgan Purevdorj; Bayarmaa Nyamaa; Tulgaa Lonjid
Journal:  PLoS One       Date:  2022-10-17       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.